Patents by Inventor Birgitte Michelsen

Birgitte Michelsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7411039
    Abstract: The present invention relates to novel human glucagon-like peptide-2 (GLP-2) peptides and human glucagon-like peptide-2 derivatives which have a protracted profile of action as well as polynucleotide constructs encoding such peptides, vectors and host cells comprising and expressing the polynucleotide, pharmaceutical compositions, uses and methods of treatment.
    Type: Grant
    Filed: October 14, 2003
    Date of Patent: August 12, 2008
    Assignee: Novo Nordisk A/S
    Inventors: Lars Thim, Susanne Bang, Niels Christian Kaarsholm, Anette Sams Nielsen, Nils Langeland Johansen, Kjeld Madsen, Magali Zundel, Peter Thygesen, Birgitte Michelsen
  • Publication number: 20020193368
    Abstract: The present invention relates to the use of potassium channel agonists for the treatment of insulitis associated with various forms of diabetes such as IDDM, NIDDM, SPIDDM (LADA) and gestational diabetes.
    Type: Application
    Filed: August 6, 2002
    Publication date: December 19, 2002
    Inventors: John Bondo Hansen, Anders Karlsson, Mikael Kullin, Stellan Sandler, Elisabeth Bjork, Zhanchun Li, Birgitte Michelsen, Jesper Svendstorp Lund
  • Publication number: 20020032193
    Abstract: The present invention relates to the use of potassium channel agonists for the treatment of insulitis associated with various forms of diabetes such as IDDM, NIDDM, SPIDDM (LADA) and gestational diabetes.
    Type: Application
    Filed: June 26, 2001
    Publication date: March 14, 2002
    Inventors: John Bondo Hansen, Anders Karlsson, Mikael Kullin, Stellan Sandler, Elisabeth Bjork, Zhanchun Li, Birgitte Michelsen, Jesper Svendstorp Lund